Company insight
The fight against pharma counterfeits
Global provider SICPA offers tailor-made solutions to help pharmaceutical companies protect their business and patients.
s illicit trade continues to rise, pharmaceutical companies across the globe are implementing and upgrading its brand protection strategy. The right approach can support in managing reputational risks, brand dilution and direct loss of sales, as well as legal liability. SICPA’s brand protection solutions guarantee a secure line of defence against counterfeiting threats throughout the supply chain. Uniquely tailored to products, businesses, markets, and its customers, SICPA provides the right solution for each client. Visible and invisible security features with digital and material technologies are
A
part of a comprehensive strategy to safeguard your brand and your patients. With the right partner by your side, clients are able to: ■ ■ ■
Protect your revenue and expertise Protect your brand image
Reinforce quality-control along the supply chain
■ ■ ■
Reduce cost and time of investigations Collect legal evidence
Communicate with consumers.
To protect your business from risk or harm, SICPA offers security label solutions, packaging authentication solutions, and product authentication solutions. It integrates the most advanced
technologies into its solutions for pharmaceutical, and other healthcare providers to ensure product and supply chain integrity. The company’s state-of-the-art product QUAZAR, for example, can be used for anti-tampering seals. Meanwhile, SICPA’s covert security technology SICPAGUARD, and its overt high-security inks OASIS and STAR can be applied directly to blisters. This, in turn, allows stakeholders along the supply chain to verify the authenticity of the product. SICPA offers a comprehensive portfolio of security solutions across the globe. ●
www.brandprotection.sicpa.com
World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net
31
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53
